tumor specimens; paracancerous normal tissues; 5-FU-sensitive cancer tissues; 5-FU-resistant cancer tissues
HCT116; HCT8; HCT116/FU; HCT8/FU; NCM460; HUVECs
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); angiogenesis (promotes); apoptosis (inhibits); chemoresistance (promotes); ceRNA regulation (other); metastasis (promotes)
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Western Blot; In Vivo Animal Model
circ_0004585 is highly expressed in CRC tissues and especially in 5-FU-resistant cancer tissues, suggesting it may serve as a target for CRC treatment and drug resistance.
circ_0004585 is up-regulated in CRC tissues and cells, with even higher expression in 5-FU-resistant CRC samples and cell lines. Functionally, circ_0004585 promotes malignant phenotypes and 5-FU resistance, while its knockdown suppresses proliferation, migration, invasion, angiogenic tube formation, and tumor growth and promotes apoptosis. Mechanistically, circ_0004585 acts through the miR-874-3p/CCND1 axis to regulate CRC progression and chemoresistance.
0.6544
Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
combined biological and clinical study